Compare CVS Health Corp (CVS) vs iShares MSCI Hong Kong ETF (EWH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs iShares MSCI Hong Kong ETF — how do they compare? CVS Health Corp trades at $93.68 (market cap $122.36B), while iShares MSCI Hong Kong ETF trades at $22.2. The key difference: CVS Health Corp pays a 2.78% dividend while iShares MSCI Hong Kong ETF pays none, and CVS Health Corp is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals.
| CVS | EWH | |
|---|---|---|
Market Cap | $122.36B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $110.60 | $24.55 |
52-Week Low | $65.51 | $20.66 |
Enterprise Value | $184.71B | — |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
EWH trades at $22.71 with a 0.98% daily gain, showing neutral technical signals overall. The ETF tracks Hong Kong equities, with recent momentum in the Hang Seng Index providing support. Moving averages indicate bullish momentum while oscillators remain neutral. The fund declared a $0.35 dividend payable in June 2026, offering income potential alongside capital appreciation.
Outlook remains balanced with technical strength offset by valuation concerns. Key opportunities include Hong Kong market recovery and technology sector momentum, while risks involve Asian market volatility and geopolitical tensions. The neutral technical stance suggests waiting for clearer directional signals before establishing new positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →
